Note: This document has been translated from the Japanese original for reference purpose only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
August 5, 2025
Trade name: Noevir Holdings Co., Ltd.
Listing: Tokyo Stock Exchange, Prime Market (Securities Code: 4928) URL: https://www.noevirholdings.co.jp/
Representative: Takashi Okura, President and CEO Contact: Junya Baba, General Manager, Accounting
Tel. +81-78-303-5121
Date of commencement of dividend payments: -
Supplemental materials for the financial results prepared: None Results briefing for the reporting period held: None
(Amounts under one million yen have been rounded down)
Operating results for the first nine months of the fiscal year ending September 30, 2025 (October 1, 2024 to June 30, 2025)
Consolidated operating results
(Millions of yen; percentage figures denote year-on-year change)
Net sales
Operating income
Ordinary income
Net income attributable to owners of the parent
Nine months ended June 30, 2025
47,283 (2.0) %
8,008
(11.2) %
8,422
(8.1) %
4,123
(8.2) %
Nine months ended June 30, 2024
48,238 2.9 %
9,015
2.7 %
9,169
2.3 %
4,490
(4.4) %
Note: Comprehensive income:
Nine months ended June 30, 2025: 4,168 million yen [(21.5)%]
Nine months ended June 30, 2024: 5,309 million yen [(2.6)%]
EPS (Yen)
Diluted EPS (Yen)
Nine months ended June 30, 2025
120.73
-
Nine months ended June 30, 2024
131.48
-
Consolidated financial position
(Millions of yen)
Total assets
Net assets
Equity ratio (%)
As of June 30, 2025
73,359
50,389
67.9
As of September 30, 2024
76,471
53,906
69.9
[Reference] Equity:
As of June 30, 2025: 49,820 million yen
As of September 30, 2024: 53,477 million yen
Cash dividends
(Yen)
Annual dividends
1st quarter
2nd quarter
3rd quarter
Year-end
Total
Fiscal year ended September 30, 2024
-
0.00
-
225.00
225.00
Fiscal year ending September 30, 2025
-
0.00
-
Fiscal year ending September 30, 2025 (forecast)
225.00
225.00
Note: Revisions from the most recently announced dividend forecast: None
Consolidated earnings forecasts for the fiscal year ending September 30, 2025 (October 1, 2024 to September 30, 2025)
(Millions of yen; percentage figures denote year-on-year change)
Net sales | Operating | income | Ordinary | income | Net income attributable to owners of the parent | EPS (Yen) | |||
Full year | 64,000 | 0.3% | 11,500 | 0.7% | 11,700 | 0.9% | 8,000 | 0.4% | 234.22 |
Note: Revisions from the most recently announced consolidated earnings forecast: None
* Notes
Significant changes in the scope of consolidation during the period: None
Special accounting treatment for preparation of quarterly consolidated financial statements: None
Changes in accounting policies, changes in accounting estimates, and restatement
Changes associated with revision in accounting standards: Yes
Other changes: None
Changes in accounting estimates: None
Restatement: None
Shares outstanding (common stock)
Shares outstanding (including treasury stock) As of June 30, 2025: 34,156,623
As of September 30, 2024: 34,156,623
Treasury shares outstanding As of June 30, 2025: 416
As of September 30, 2024: 416
Average shares outstanding over quarter
Nine months ended June 30, 2025: 34,156,207
Nine months ended June 30, 2024: 34,156,345
Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: None
Explanation regarding the appropriate use of business performance forecasts
Forward-looking statements included in these materials, such as forecasts of business performance, are based on information known to the Company's management as of the time of writing, and reflect judgments believed to be reasonable on the basis of that information. There is, therefore, a possibility that actual business performance figures will differ substantially from our forecasts as a result of changes in the economic situation and other unforeseeable factors. Please refer to "(3) Estimates and forecasts pertaining to future plans and business results" under "1. Operating results and financial information" on page 5 of the Attached Material.
Contents of the Attached Material
Operating results and financial information 4
Operating results for the first nine months of the fiscal year ending September 30, 2025 4
Financial position as of June 30, 2025 4
Estimates and forecasts pertaining to future plans and business results 5
Quarterly consolidated financial statements and notes 6
Quarterly consolidated balance sheets 6
Quarterly consolidated statements of income and comprehensive income 8
Quarterly consolidated statements of cash flows 10
Notes to quarterly consolidated financial statements 11
(Note on assumptions for going concern) 11
(Note on significant changes in the amount of shareholders' equity) 11
(Note on changes in accounting policies) 11
(Note on segment information) 12
Operating results and financial information
Operating results for the first nine months of the fiscal year ending September 30, 2025 Consolidated operating results for the first nine months of the fiscal year ending September 30, 2025 (October 1, 2024 to June 30, 2025)
Nine months ended
June 30, 2024
Nine months ended
June 30, 2025
Change (Millions of yen)
Change (%)
Net sales (Millions of yen)
% of Total
Net sales (Millions of yen)
% of Total
Net sales
48,238
100.0
47,283
100.0
(955)
(2.0)
Cosmetics
38,099
79.0
37,412
79.1
(686)
(1.8)
Pharmaceuticals & Health Food
8,265
17.1
8,374
17.7
109
1.3
Other
1,873
3.9
1,495
3.2
(377)
(20.2)
Nine months ended June 30, 2024
Nine months ended June 30, 2025
Change (Millions of yen)
Change (%)
Amount (Millions of yen)
% of Net sales
Amount (Millions of yen)
% of Net sales
Operating income
9,015
18.7
8,008
16.9
(1,007)
(11.2)
Ordinary income
9,169
19.0
8,422
17.8
(747)
(8.1)
Net income attributable to owners of the parent
4,490
9.3
4,123
8.7
(367)
(8.2)
During the first nine months of fiscal 2025 (October 1, 2024 to June 30, 2025), economic trends remained uncertain, although some signs of gradual recovery were observed.
In this environment, the Company is working to realize the concept of its medium- to long-term strategy: "Realizing steady corporate growth by securing sustainability in every Group business segment."
As a result, net sales for the first nine months of fiscal 2025 came to 47,283 million yen (down 2.0% year on year), operating income was 8,008 million yen (down 11.2%), ordinary income was 8,422 million yen (down 8.1%), and net income attributable to owners of the parent came to 4,123 million yen (down 8.2%).
In the Cosmetics segment, net sales totaled 37,412 million yen (down 1.8% year on year), and segment income came to 8,974 million yen (down 6.6%).
In the Pharmaceuticals & Health Food segment, net sales totaled 8,374 million yen (up 1.3% year on year), and segment income came to 746 million yen (down 21.7%).
In the Other segment, net sales totaled 1,495 million yen (down 20.2% year on year), and segment income came to 137 million yen (down 38.2%).
Financial position as of June 30, 2025
Total assets as of June 30, 2025 stood at 73,359 million yen, a decrease of 3,112 million yen from the previous fiscal year-end. This was mainly due to a decrease in cash and deposits of 13,752 million yen and an increase in securities of 9,996 million yen.
Total liabilities came to 22,969 million yen, an increase of 404 million yen from the previous fiscal year-end. This mainly reflected an increase in income tax payable of 818 million yen and a decrease in net defined benefit liability of 547 million yen.
Net assets came to 50,389 million yen, a decrease of 3,516 million yen from the previous fiscal year-end.
This was primarily attributable to a decrease in retained earnings of 3,561 million yen, due to the payment of 7,685 million yen in dividends at the previous fiscal year-end, which was partly offset by net income attributable to owners of the parent of 4,123 million yen.
As a result, the equity ratio stood at 67.9%.
(Consolidated cash flows)
Cash and cash equivalents (hereinafter, "cash") on a consolidated basis as of the end of the period under review stood at 15,264 million yen, a decrease of 13,742 million yen compared with the previous fiscal year-end.
The status of each cash flow together with the factors contributing to their increase or decrease for the first nine months of fiscal 2025 are presented as follows.
(Cash flows from operating activities)
Net cash provided by operating activities amounted to 5,807 million yen (compared with an inflow of 7,533 million yen in the corresponding period of the previous fiscal year). The main item increasing cash was 8,523 million yen in income before income taxes, and the main item decreasing cash was 3,144 million yen in net income tax paid.
(Cash flows from investing activities)
Net cash used in investing activities came to 11,869 million yen (compared with an inflow of 1,781 million yen in the corresponding period of the previous fiscal year). The principal cash outflow was 19,985 million yen for purchase of securities, whereas the principal cash inflow was 10,006 million yen in proceeds from redemption of securities.
(Cash flows from financing activities)
Net cash used in financing activities came to 7,747 million yen (compared with an outflow of 7,585 million yen in the corresponding period of the previous fiscal year). This was mainly due to the payment of 7,683 million yen in dividends.
Estimates and forecasts pertaining to future plans and business results
The consolidated business performance forecasts for the full year ending September 30, 2025, announced on November 8, 2024, remain unchanged.